Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

OBJECTIVE: Accumulating evidence from recent molecular diagnostic studies has indicated the prognostic significance of various genetic markers for patients with glioblastoma (GBM). To evaluate the impact of such genetic markers on prognosis, we retrospectively analyzed the outcomes of patients with...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Med
Huvudupphovsmän: Funakoshi, Yusuke, Hata, Nobuhiro, Takigawa, Kosuke, Arita, Hideyuki, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Sako, Aki, Umehara, Toru, Yoshitake, Tadamasa, Togao, Osamu, Hiwatashi, Akio, Yoshimoto, Koji, Iwaki, Toru, Mizoguchi, Masahiro
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2021
Ämnen:
Clinical Cancer Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8124111/
https://ncbi.nlm.nih.gov/pubmed/33838014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3860
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk